We are live on ! Find out more
SCM

SKBA Capital Management Portfolio holdings

AUM $728M
1-Year Est. Return 12.18%
This Fund
S&P 500
This Quarter Est. Return
+20.14%
1 Year Est. Return
+12.18%
3 Year Est. Return
+52.29%
5 Year Est. Return
+76.86%
10 Year Est. Return
+235.51%
AUM
$597M
AUM Growth
+$96M
Cap. Flow
+$4.99M
Cap. Flow %
0.84%
Top 10 Hldgs %
28.32%
Holding
80
New
8
Increased
30
Reduced
24
Closed
4

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$9.19M
2
CB icon
Chubb
CB
+$5.75M
3
CAH icon
Cardinal Health
CAH
+$5.55M
4
CME icon
CME Group
CME
+$5.51M
5
VTRS icon
Viatris
VTRS
+$5.16M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$6.85M
2
KMB icon
Kimberly-Clark
KMB
+$5.32M
3
CVS icon
CVS Health
CVS
+$4.92M
4
ETN icon
Eaton
ETN
+$4.86M
5
INTC icon
Intel
INTC
+$4.83M

Sector Composition

Rank Sector Weight
1 Financials 19.94%
2 Healthcare 16%
3 Industrials 11.27%
4 Consumer Staples 9.47%
5 Energy 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
1
AbbVie
ABBV
$458B
$19.9M 3.33%
185,778
-100
-0.1% -$9.61K
CMCSA icon
2
Comcast
CMCSA
$79.1B
$18.7M 3.14%
357,560
+400
+0.1% +$19.2K
NTAP icon
3
NetApp
NTAP
$32.9B
$18.5M 3.09%
278,900
– –
AIG icon
4
American International
AIG
$41.9B
$17.8M 2.98%
470,295
+20,150
+4% +$710K
VZ icon
5
Verizon
VZ
$194B
$17.6M 2.94%
298,980
+600
+0.2% +$35.6K
AMGN icon
6
Amgen
AMGN
$203B
$17.3M 2.9%
75,370
+18,100
+32% +$4.17M
AMP icon
7
Ameriprise Financial
AMP
$46.8B
$15.5M 2.59%
79,550
– –
TGT icon
8
Target
TGT
$62.1B
$14.9M 2.49%
84,180
-28,250
-25% -$4.71M
COP icon
9
ConocoPhillips
COP
$147B
$14.8M 2.48%
370,080
+81,700
+28% +$3.01M
MRK icon
10
Merck
MRK
$324B
$14.2M 2.37%
181,618
+120,205
+196% +$9.19M
NTR icon
11
Nutrien
NTR
$32.7B
$14M 2.34%
290,670
+240
+0.1% +$10.6K
CSCO icon
12
Cisco
CSCO
$450B
$13.8M 2.31%
308,230
-1,300
-0.4% -$53.4K
CMI icon
13
Cummins
CMI
$91.7B
$13.7M 2.3%
60,520
-13,650
-18% -$3.07M
CTVA icon
14
Corteva
CTVA
$59.7B
$13.2M 2.21%
341,314
-21,700
-6% -$776K
PB icon
15
Prosperity Bancshares
PB
$8.77B
$13M 2.18%
188,050
– –
KTB icon
16
Kontoor Brands
KTB
$4.62B
$13M 2.18%
321,064
-1,100
-0.3% -$40.5K
PSX icon
17
Phillips 66
PSX
$82.9B
$13M 2.18%
185,860
+24,700
+15% +$1.45M
RIO icon
18
Rio Tinto
RIO
$148B
$12.9M 2.16%
171,300
+8,950
+6% +$588K
ATCO
19
DELISTED
Atlas Corp.
ATCO
$12.5M 2.1%
1,154,920
+185,500
+19% +$1.91M
MDT icon
20
Medtronic
MDT
$107B
$12M 2.01%
102,646
+10,800
+12% +$1.19M
MET icon
21
MetLife
MET
$61B
$12M 2.01%
255,500
-60,000
-19% -$2.6M
UNP icon
22
Union Pacific
UNP
$183B
$11.9M 1.99%
57,190
-5,800
-9% -$1.16M
CB icon
23
Chubb
CB
$140B
$11.6M 1.95%
75,600
+41,000
+118% +$5.75M
C icon
24
Citigroup
C
$222B
$11.6M 1.94%
187,550
– –
TEL icon
25
TE Connectivity
TEL
$58.8B
$11.5M 1.92%
94,652
-14,500
-13% -$1.6M
1
2 3 4

Similar funds

SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return
TVPW
Third View Private Wealth Westport, Connecticut $730M AUM
DA
Dillon & Associates Jackson, Michigan $726M AUM 18.59% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $732M AUM 28.13% 1-Year Est. Return
TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return

SKBA Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, SKBA Capital Management held 80 positions worth $597M, up 19% from $501M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

SKBA Capital Management's Q4 2020 filing shows 8 new, 30 increased, 24 reduced and 4 closed positions. Its largest new stake was CME Group: 32,400 shares worth $5.9M. The largest sale was Gilead Sciences, an estimated $6.85M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

  • SKBA Capital Management's largest Q4 2020 buy was CME Group: 32,400 shares worth $5.9M.
  • SKBA Capital Management added most to Merck in Q4 2020, an estimated $9.19M increase.
  • SKBA Capital Management's biggest Q4 2020 reduction was Eaton, cutting an estimated $4.86M.
  • SKBA Capital Management fully exited Gilead Sciences in Q4 2020, selling an estimated $6.85M.
  • SKBA Capital Management's ten largest holdings make up 28% of its $597M portfolio in Q4 2020.
  • SKBA Capital Management opened 8 new positions and closed 4 in Q4 2020.
  • SKBA Capital Management's portfolio value rose 19% quarter-over-quarter to $597M.

Based on SKBA Capital Management's 13F filing for Q4 2020, filed 10 Feb 2021.